AGM Statement
Summary by AI BETAClose X
One Health Group plc
("One Health", the "Company" or the “Group”)
AGM Statement
One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through ‘Patient Choice’, provides an update to shareholders ahead of its Annual General Meeting (“AGM”) being held today at 11:00 a.m. at 131 Psalter Lane, Sheffield S11 8UX.
Addressing shareholders, Derek Bickerstaff, Chairman, will provide the following statement:
“I am pleased to announce that trading in the early part of the year ending 31 March 2027 (“FY 2027”) remains strong and in line with management expectations. Demand for NHS-funded elective care remains significant, and the Company is well positioned to continue supporting patients by providing much-needed care in areas with low NHS provision.
“Construction of our first surgical hub in Scunthorpe remains a key strategic milestone. I am delighted that the project is progressing well and remains on track to be delivered within the one-year construction period and within the original £8m to £9m construction cost estimate. The facility is expected to open in Spring 2027.
“Further sections of the roof have now been completed, an important milestone as the building moves towards becoming weather-tight ahead of autumn and winter, allowing an increasing level of internal activity to take place. Mechanical and electrical installation is also progressing, including first-fix work for key services such as wiring and pipework. Multiple trades are now operating concurrently across the site as the project moves into a more advanced phase of construction.
“Once operational, the surgical hub will provide an efficient, high-volume model of care, supporting the delivery of NHS-funded elective procedures. The facility will give patients greater access to treatment through the NHS Patient Choice pathway, whilst also helping to make more efficient use of NHS resources. The development is also intended to become a long-term healthcare asset for the local community, creating additional capacity in the region and supporting the delivery of planned surgery closer to where patients live. By providing dedicated surgical facilities, the hub will complement the existing NHS provision and help create greater flexibility in how and where patients can receive treatment.
“We anticipate continued growth in demand for our services from the NHS during FY 2027 and beyond, alongside the progression of our first surgical hub, which will deliver strategically important surgical capacity growth in underserved areas. The Company remains well placed to support the increasing demands of NHS commissioners and NHS patients through the delivery of more local healthcare, free at the point of use.
“We will continue to update shareholders on the surgical hub build and execution of our medium to long term growth strategy, which builds on the Company’s ongoing model of strong organic growth. We look forward to providing a further trading update for the six months ending 30 September 2026 in late October.”
If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com
This announcement contains inside information for the purposes of the UK Market Abuse Regulation
and the Directors of the Company are responsible for the release of this announcement.
For more information, please contact:
|
One Health Group plc Derek Bickerstaff, Chairman Adam Binns, CEO
|
Via Walbrook PR |
|
|
Panmure Liberum (Nominated Adviser and Broker) Emma Earl, Will Goode, Mark Rogers Rupert Dearden
|
Tel: +44 (0)20 3100 2000 |
|
|
Walbrook PR (Media & Investor Relations) Alice Woodings, Paul McManus, Rachel Broad |
Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 / +44 (0)7747 515 393 |
|
|
|
||
About One Health Group plc (www.onehealth.co.uk)
One Health engages 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2026 provided much needed care to almost 19,000 new patients, through over 50,000 consultations and over 8,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 140 professionals across 14 independent hospitals and 40 outreach clinics. Within these community-based outreach clinics all consultations and post-operative physiotherapy is delivered where required, reducing patient inconvenience, excess travel and distress.
One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment.
One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, which represent the majority of the national waiting list, with urology introduced at the end of FY25.
Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.
Online investor presentation
Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company’s financial results for the year ended 31 March 2026, growth strategy and long-term vision: https://www.investormeetcompany.com/meetings/investor-presentation-1068
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 12 hours ago Rathbones Group
- 12 hours ago Raspberry PI Holdings (WI)
- 13 hours ago Alumasc Group
- 13 hours ago Land Securities Group
- 14 hours ago Computacenter